Sanofi-Aventis - Comparative Multiple Analysis

Sanofi-Aventis (Comparative Multiple Analysis)

Home Comparative Index Sanofi-Aventis

►Summary | Profile | News | Chart | SWOT | Cash Flow | Comps | Buffett | WACC

Link to services page

placeholder_large_analysis.png

Improve your investment analysis with by seeing the Sanofi-Aventis's Discounted Cash Flow analysis, Sanofi-Aventis's Warren Buffet analysis, and Sanofi-Aventis's Weighted Average Cost of Capital (WACC) Analysis.

Notes on the Comparative Multiple Analysis of Sanofi-Aventis

WikiWealth compares Sanofi-Aventis's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Sanofi-Aventis's comparative analysis.

Notes from the analysis:

1. WikiWealth uses quantitative measures to determine the multiple range for Sanofi-Aventis.
2. Free cash flow to the firm (FCF) multiple is free cash flow to equity holders plus interest owed to Sanofi-Aventis's debt holders.
3. Multiples incorporate benefits due to economies of scale; WikiWealth compares absolute enterprise value multiples to competitor's multiples.
4. WikiWealth excludes outliers when calculating individual company multiples.

Helpful Information for Sanofi-Aventis's Analysis


How does this work? The Comparative Investment Analysis determines the value of Sanofi-Aventis by comparing Sanofi-Aventis financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.

Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Sanofi-Aventis.

See the Sanofi-Aventis cash flow (DCF) analysis for a completely different approach that's popular on Wall Street for determining the value of an investment in Sanofi-Aventis.

Also, see the Sanofi-Aventis's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Sanofi-Aventis's valuation conclusion for a quick summary.